Effects of Dapagliflozin on 24-h Glycemic Changes in Japanese Patients with type 2 Diabetes Mellitus (T2DM), who Receives Basal supported Oral Therapy - DBOT

Tokushima University Graduate School0 个研究点目标入组 36 人开始时间: 2015年11月1日最近更新: 2023年11月20日

适应症

试验速览

•1. Type 1 diabetes mellitus, secondary diabetes mellitus 2. 3. Patients who have complications of severe hepatic disease , severe renal disease or receiving dialysis or recent 5 years malignancies. Patients with cardiovascular diseases (recent cardiovascular events, congestive heart failure, patients with uncontrolled high blood pressure) 4. Volume depleted patients (the study intends to enroll elderly patients over 65 who are more prone to volume depletion due to co-existing conditions and concomitant medications such as loop diuretics) 5. Patients with pregnancy, possible pregnancy, or on breast-feeding 6. Contraindication for the use of dapagliflozin 7. Patients who were received other sodium glucose cotransporter 2 inhibitor 8. Disqualified from the study by the primary investigator or a sub-investigator for any reason other than given above.

发起方

Tokushima University Graduate School